LAFFI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.979
EU - Europa 12.439
AS - Asia 7.945
SA - Sud America 924
AF - Africa 231
OC - Oceania 165
Continente sconosciuto - Info sul continente non disponibili 2
Totale 42.685
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.790
RU - Federazione Russa 4.606
SG - Singapore 2.210
PL - Polonia 2.041
CN - Cina 1.649
HK - Hong Kong 1.458
SE - Svezia 1.209
IE - Irlanda 1.135
VN - Vietnam 883
IT - Italia 868
BR - Brasile 772
KR - Corea 751
DE - Germania 599
UA - Ucraina 553
FI - Finlandia 428
FR - Francia 385
GB - Regno Unito 288
IN - India 239
JP - Giappone 194
AU - Australia 163
JO - Giordania 113
CA - Canada 110
TR - Turchia 104
CH - Svizzera 87
BD - Bangladesh 66
NL - Olanda 66
CI - Costa d'Avorio 60
AR - Argentina 54
ID - Indonesia 50
BE - Belgio 43
IQ - Iraq 42
MX - Messico 41
NG - Nigeria 38
ZA - Sudafrica 32
PK - Pakistan 28
ES - Italia 27
EC - Ecuador 24
MA - Marocco 24
UZ - Uzbekistan 24
EG - Egitto 23
SC - Seychelles 18
VE - Venezuela 18
CO - Colombia 17
AE - Emirati Arabi Uniti 16
SA - Arabia Saudita 13
AZ - Azerbaigian 11
PE - Perù 11
AL - Albania 10
AT - Austria 10
CL - Cile 10
CZ - Repubblica Ceca 10
PH - Filippine 9
PY - Paraguay 9
BG - Bulgaria 8
DZ - Algeria 8
KE - Kenya 8
MY - Malesia 8
PT - Portogallo 8
CR - Costa Rica 7
TH - Thailandia 7
TN - Tunisia 7
KZ - Kazakistan 6
LT - Lituania 6
NP - Nepal 6
RO - Romania 6
SY - Repubblica araba siriana 6
DK - Danimarca 5
HU - Ungheria 5
IL - Israele 5
JM - Giamaica 5
KG - Kirghizistan 5
LV - Lettonia 5
OM - Oman 5
PA - Panama 5
TW - Taiwan 5
UY - Uruguay 5
AM - Armenia 4
BO - Bolivia 4
BY - Bielorussia 4
HN - Honduras 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TT - Trinidad e Tobago 4
DO - Repubblica Dominicana 3
EE - Estonia 3
GR - Grecia 3
GT - Guatemala 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
MT - Malta 3
NI - Nicaragua 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
EU - Europa 2
IR - Iran 2
Totale 42.655
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.415
Warsaw 2.032
Ashburn 1.903
Fairfield 1.881
Singapore 1.507
Hong Kong 1.202
Chandler 1.190
Dublin 1.135
San Jose 896
Jacksonville 889
Woodbridge 838
Cambridge 776
Seattle 768
Seoul 745
Houston 642
Wilmington 641
Beijing 534
Los Angeles 377
Ann Arbor 369
Buffalo 315
Princeton 287
The Dalles 284
Ho Chi Minh City 264
Lauterbourg 241
Boston 229
Boardman 216
Hanoi 207
Lawrence 207
Altamura 202
Dallas 189
Tokyo 176
Melbourne 161
Hefei 145
Mumbai 131
Munich 126
Moscow 120
Florence 113
Medford 111
New York 107
San Diego 107
Helsinki 100
Shanghai 89
Bern 85
Paris 80
Bremen 69
Izmir 67
São Paulo 61
Turku 61
Abidjan 60
Council Bluffs 58
Norwalk 57
London 53
Milan 53
Kent 51
Redondo Beach 44
Da Nang 42
Frankfurt am Main 42
Orem 41
Guangzhou 37
Toronto 37
Abuja 36
Brussels 34
Haiphong 33
Dong Ket 32
Hillsboro 32
Montreal 31
Rome 31
Andover 30
Jakarta 30
Chicago 28
Falls Church 28
Brooklyn 27
Auburn Hills 26
Chennai 23
Tashkent 23
Verona 23
Phoenix 22
Yubileyny 22
Salerno 21
Stockholm 21
Clifton 20
Rio de Janeiro 20
Dearborn 19
Hải Dương 19
Manchester 19
Belo Horizonte 18
Biên Hòa 18
Tianjin 18
Atlanta 17
Frankfurt Am Main 17
Washington 17
Dhaka 16
Osaka 16
Amsterdam 15
Bari 15
Brasília 15
Denver 15
San Francisco 15
Amman 14
Baghdad 14
Totale 28.755
Salva come PNG Salva come JPEG
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 359
Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. 340
Acute on chronic liver failure: From pathophysiology to clinical management. 326
Complete resolution of primary sclerosing peritonitis ("abdominalCocoon") following long term therapy for tropheryma whipplei: a case report and review of literature. 322
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 315
Macro-aspartate aminotransferase in a healthy woman 313
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study 313
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 308
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 307
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 305
Neuroendocrine dysregulation in irritable bowel syndrome patients: A pilot study 300
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 299
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment. 299
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 271
Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma 265
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 260
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma. 258
Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A. 248
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 245
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 239
The kinin system and other vasoactive substances in chronic liver disease. 235
[Renal function in chronic hepatopathies] 230
[Some aspects of the physiopathology of renal insufficiency in the course of chronic liver diseases] 230
Acute viral hepatitis increases liver stiffness values measured by transient elastography 228
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 219
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 218
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 218
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 214
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 211
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 210
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 208
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 207
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 207
DRESS syndrome in a patient with chronic hepatic encephalopathy. 204
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 203
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 202
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 200
ADMA correlates with portal pressure in patients with compensated cirrhosis. 199
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 199
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 199
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 197
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 195
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 194
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 193
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 192
Host genetic determinants in HCV-related mixed cryoglobulinemia 190
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 189
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany 185
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 184
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 184
Analysis of HCV persistence in patients with sustained virological response 182
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 182
Defective aggregation in cirrhosis is independent of in vivo platelet activation. 182
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 182
[Hearing threshold of workers not exposed to occupational noise: reference values] 181
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 181
Functional insufficiency in chronic liver disease patients. The hepatorenal syndrome 181
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 180
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 179
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 179
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 177
Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists 177
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 177
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 176
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 176
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 175
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. 174
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 174
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 174
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 173
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. 173
Nuclear localization of TRK-A in liver cells. 172
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 172
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 172
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 172
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 172
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 171
Screening of distress among hospitalized patients in a department of internal medicine. 171
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 170
Functional renal alterations in chronic liver diseases. 170
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 170
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 170
Adiponectin and the cardiovascular system: from risk to disease. 169
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 169
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 168
Age-dependent association of exposure to television screen with children's urinary melatonin excretion? 168
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation 167
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 167
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells 167
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 167
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. 166
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 165
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 164
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 164
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 164
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 164
Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib 164
Serotonin and its implication in the side-effects of interferon-based treatment of patients with chronic viral hepatitis: Pharmacological interventions 163
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 163
Totale 20.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.301
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021411 0 0 0 0 0 0 0 0 0 0 173 238
2021/20221.845 45 190 92 79 69 71 76 111 92 63 402 555
2022/20235.035 466 677 269 386 451 938 673 312 569 24 146 124
2023/20241.593 68 209 306 91 102 231 45 357 22 45 56 61
2024/202512.374 411 1.269 829 1.929 3.966 1.413 124 784 607 293 397 352
2025/202610.539 1.527 1.683 772 1.086 1.329 403 1.411 526 999 720 83 0
Totale 42.777